Literature DB >> 1712048

Case for prostate therapy wanes despite more treatment options.

P Cotton.   

Abstract

Mesh：

Year:  1991        PMID： 1712048     DOI： 10.1001/jama.266.4.459

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy.

Authors:  Ali Zekri; Seyed H Ghaffari; Samad Ghanizadeh-Vesali; Marjan Yaghmaie; Arash Salmaninejad; Kamran Alimoghaddam; Mohammad H Modarressi; Ardeshir Ghavamzadeh
Journal:  Tumour Biol       Date:  2014-10-03

2.  Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia.

Authors:  D Giri; M Ittmann
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 3.  Appropriate indications for prostatectomy in the UK--results of a consensus panel.

Authors:  D J Hunter; C M McKee; C F Sanderson; N A Black
Journal:  J Epidemiol Community Health       Date:  1994-02       Impact factor: 3.710

4.  Health care sought and received by men with urinary symptoms, and their views on prostatectomy.

Authors:  D J Hunter; C M McKee; N A Black; C F Sanderson
Journal:  Br J Gen Pract       Date:  1995-01       Impact factor: 5.386
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.